Search - tctmd.com

Displaying 641 - 660 of 746

Sort: Relevancy | Date

Presentation TCT 2016

Poland Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure?

Presenter: Dariusz Dudek, Petr Kala, Andrzej J. Ochala

October 30, 2016

Presentation TCT 2016

Czech Republic Presents: How Did I Treat This Case?

Presenter: Eric Van Belle, Jochen Wöhrle, Marian Branny

October 30, 2016

Presentation TCT 2016

Poland Responds: How Would I Treat This Case?

Presenter: Eric Van Belle, Jochen Wöhrle, Marek Grygier

October 30, 2016

Presentation TCT 2016

Czech Republic Presents: A Case of Ostial LAD Undergoing TAVR: Staged or Single Procedure?

Presenter: Eric Van Belle, Jochen Wöhrle, Marian Branny

October 30, 2016

Presentation TCT 2016

France Presents: How Did I Treat This Case?

Presenter: Eric Van Belle, Jochen Wöhrle, Flavien Vincent

October 30, 2016

Presentation TCT 2016

France Presents: A Patient With Critical CAD and Aortic Stenosis Undergoing TAVR: Staged or Single Procedure?

Presenter: Eric Van Belle, Jochen Wöhrle, Flavien Vincent

October 30, 2016

Presentation TCT 2016

Poland Presents: Treatment Options - Should Severe Coronary Artery Disease Be Treated Prior, During, or After TAVR (and in a Single or Staged Procedure)?

Presenter: Eric Van Belle, Jochen Wöhrle, Dariusz Dudek

October 30, 2016

Presentation TCT 2016

Introduction and Session Objectives

Presenter: Eric Van Belle, Jochen Wöhrle

October 30, 2016

Presentation TVT 2016

TAVR in Bicuspid Aortic Valve Disease: Anatomic Variations, TAVR Outcomes, and Treatment Guidelines How to Treat and When Not to Treat

Presenter: Mathew Williams

June 17, 2016

Presentation TVT 2016

Combined TAVR and Left Atrial Appendage Closure in AS Patients With Atrial Fibrillation: Case Selection, Procedural Consideration, and Clinical Outcomes

Presenter: Fabian Nietlispach

June 17, 2016

Presentation TVT 2016

Complexities of Managing AS Patients With Atrial Fibrillation After TAVR

Presenter: Samir R. Kapadia

June 17, 2016

Presentation TVT 2016

Is There a Role For MitraClip After TAVR in Patients With Significant Residual MR?

Presenter: Brij Maini

June 17, 2016

Presentation TVT 2016

Management Decisions in the Patient With Severe AS and Mitral Regurgitation

Presenter: Marco Barbanti

June 17, 2016

Presentation TVT 2016

Introducing the UNLOAD TAVR Study: Potential Clinical Benefits of TAVR in Patients With Moderate AS and Reduced-EF Heart Failure

Presenter: Nicolas M. Van Mieghem

June 17, 2016

Presentation TVT 2016

The Case for Accelerating Therapy in Patients With Asymptomatic Severe AS

Presenter: Philippe Généreux

June 17, 2016

Presentation TVT 2016

The AS Patient With Severe Lung Disease: Screening and Management Decisions

Presenter: Brij Maini

June 17, 2016

Presentation TVT 2016

Left Main Coronary Disease and AS: Management Approaches With Case Examples

Presenter: Raj Makkar

June 17, 2016

Presentation TVT 2016

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

Presenter: Ganesh Manoharan

June 17, 2016

Presentation TVT 2016

Replacing the Valve Is Usually Sufficient to Manage Severe AS and Coronary Disease

Presenter: Mark J. Russo

June 17, 2016

Presentation TVT 2016

State-of-the-Art Approach to TAVR in Bicuspid Aortic Valve Disease: From Patient Screening to Device Selection and Procedural Techniques

Presenter: Horst Sievert

June 16, 2016

Advertisement

Poland Presents: A Patient with Severe Aortic Stenosis and Mitral Regurgitation; Single or Staged Procedure?

Czech Republic Presents: How Did I Treat This Case?

Poland Responds: How Would I Treat This Case?

Czech Republic Presents: A Case of Ostial LAD Undergoing TAVR: Staged or Single Procedure?

France Presents: How Did I Treat This Case?

France Presents: A Patient With Critical CAD and Aortic Stenosis Undergoing TAVR: Staged or Single Procedure?

Poland Presents: Treatment Options - Should Severe Coronary Artery Disease Be Treated Prior, During, or After TAVR (and in a Single or Staged Procedure)?

Introduction and Session Objectives

TAVR in Bicuspid Aortic Valve Disease: Anatomic Variations, TAVR Outcomes, and Treatment Guidelines How to Treat and When Not to Treat

Combined TAVR and Left Atrial Appendage Closure in AS Patients With Atrial Fibrillation: Case Selection, Procedural Consideration, and Clinical Outcomes

Complexities of Managing AS Patients With Atrial Fibrillation After TAVR

Is There a Role For MitraClip After TAVR in Patients With Significant Residual MR?

Management Decisions in the Patient With Severe AS and Mitral Regurgitation

Introducing the UNLOAD TAVR Study: Potential Clinical Benefits of TAVR in Patients With Moderate AS and Reduced-EF Heart Failure

The Case for Accelerating Therapy in Patients With Asymptomatic Severe AS

The AS Patient With Severe Lung Disease: Screening and Management Decisions

Left Main Coronary Disease and AS: Management Approaches With Case Examples

Severe Chronic Kidney Disease and TAVR: Clinical Management Recommendations

Replacing the Valve Is Usually Sufficient to Manage Severe AS and Coronary Disease

State-of-the-Art Approach to TAVR in Bicuspid Aortic Valve Disease: From Patient Screening to Device Selection and Procedural Techniques

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content